van Son, Marieke J. http://orcid.org/0000-0002-1886-6385
Peters, Max http://orcid.org/0000-0002-7981-5768
Reddy, Deepika
Shah, Taimur T.
Hosking-Jervis, Feargus
Robinson, Stephen http://orcid.org/0000-0003-0623-4636
Lagendijk, Jan J. W.
Mangar, Stephen
Dudderidge, Tim
McCracken, Stuart
Hindley, Richard G.
Emara, Amr
Nigam, Raj
Persad, Raj
Virdi, Jaspal
Lewi, Henry
Moore, Caroline http://orcid.org/0000-0003-0202-7912
Orczyk, Clement
Emberton, Mark http://orcid.org/0000-0003-4230-0338
Arya, Manit
Ahmed, Hashim U. http://orcid.org/0000-0003-1674-6723
van der Voort van Zyp, Jochem R. N.
Winkler, Matt http://orcid.org/0000-0002-2553-5816
Falconer, Alison
Article History
Received: 27 December 2020
Revised: 14 March 2021
Accepted: 15 April 2021
First Online: 1 May 2021
Compliance with ethical standards
:
: Dr Peters and Dr van der Voort van Zyp received a research grant from the Dutch Cancer Society. Dr Reddy received a research grant from Prostate Cancer UK and received travel grants from Imperial Health Charity and Sonacare. Dr Shah received funding from Prostate Cancer UK and the St Peters Trust and has received funding in the past for conference attendance from Astellas, Ferring and Galil Medical. Professor Moore receives funding from the National Institute for Health Research, The European Association of Urology Research Foundation, MRC, Cancer Research UK, Prostate Cancer UK, Movember and the Cancer Vaccine Institute for clinical prostate cancer research. She has received advisory board fees for Genomic Health. Professor Emberton’s research is supported by core funding from the United Kingdom’s National Institute of Health Research (NIHR) UCLH/UCL Biomedical Research Centre. He was awarded NIHR Senior Investigator in 2015. He receives funding from NIHR-i4i, MRC (UK), Cancer Research UK, Sonacare Inc., Trod Medical, Cancer Vaccine Institute and Sophiris Biocorp for trials in prostate cancer. He is a medical consultant to Sonacare Inc., Sophiris Biocorp, Steba Biotech, Exact Imaging and Profound Medical. Professor Ahmed’s research is supported by core funding from the United Kingdom’s National Institute of Health Research (NIHR) Imperial Biomedical Research Centre. He currently receives funding from the Wellcome Trust, Medical Research Council (UK), Prostate Cancer UK, Cancer Research UK, The BMA Foundation, The Urology Foundation, The Imperial Health Charity, Sonacare Inc., Trod Medical and Sophiris Biocorp for trials and studies in prostate cancer. He was a paid medical consultant for Sophiris Biocorp and is still a paid proctor for HIFU, cryotherapy and Rezum water vapour therapy. Dr Winkler received a travel grant and a loan of device from Zicom Biobot. The remaining authors declare no competing interests.